Motomi Mori, PhD


Knight Cancer Institute
Oregon Health & Science University
3181 SW Sam Jackson Park Road, CR 145
Portland, Oregon 97201-3098


BA (1982) University of Montana, Psychology
MS (1985) University of Iowa, Statistics
PhD (1989) University of Iowa, Biostatistics

Administrative Positions

Head, Division of Biostatistics
Director, Biostatistics Shared Resource, OHSU Cancer Institute
Director, Biostatistics & Design Program, Oregon Clinical and Translational Research Institute

Research Interests

Cancer clinical trials, statistical methods for biomarker studies, analysis of high-throughput genetics/genomics studies, survival analysis, analysis of correlated data

Recent MPH Thesis Students

Alex Foster (2008) “A Cross-Sectional Analysis of Prescription Medication Use by Children:  The Implications and Impact of Acculturation”

Sara Haidar (2008) “The Role of Obesity in Asymptomatic Prostate Inflammation:  A Cross-Sectional VA Patients in Oregon”

Rebecca Marshall (2009) “Factors Correlated with Patient Activation and Associated with Outcomed Among Patients with HIV”

Cara Varley (2009) “Retrospective Analysis of Clostridium Difficille Associated Disease at Oregon Health & Science University”

Renee Park (2009) “Nomogram Predictive of 10-Year Mortality in Differentiated Thyroid Cancer”


Recent Publications

Beer TM, Lalani AS, Lee S, Mori M, Eilers KM, Curd JG, Henner WD, Ryan CW, Venner P, Ruether JD, Chi KN and the ASCENT Investigators (2008).  C-Reactive Protein as a Prognostic Marker for Men with Androgen-Independent Prostate Cancer (AIPC):  Results from the ASCENT Trial.  Cancer 112(11):2377-2383.

Enestvedt CK, Mayo SC, Diggs BS, Mori M, Austin DA, Shipley DK, Sheppard BD, Billingsley KG (2008).  Diagnostic Laparoscopy for Patients with Potentially Resectable Pancreatic Adenocarcinoma:  Is It Cost-Effective in the Current Era?  J Gastrointest Surg 12:1177-1184.

Schnadig ID, Fromme EK, Loprinzi CL, Sloan JA, Mori M, Li H, Beer TM (2008).  Patient-Physian Disagreement Regarding Performance Status Is Associated with Worse Survivorship in Patients with Advanced Cancer.  Cancer 113(8):2205-2215.

Messaoudi I, Fischer M, Warner J, Park B, Mattison J, Ingram D, Tononchy T, Mori M, Nikolich-Zugich J (2008).  Optimal Window of Caloric Restriction Onset Limits Its Beneficial Impact Upon T Cell Senescence in Primates.  Aging Cell 7(6):908-919.

Guise JM, Deering SH, Kanki BG, Osterweil P, Li H, Mori M, Lowe NK (2008).  Validation of a Tool to Measure and Promote Clinical Teamwork.  Simulation HealthCare 2008 Winter;3(4):217-223.

Guise JM, Boyles SH, Osterweil P, Li H, Eden KB, Mori M (2009).  Does Cesarean Protect Against Fecal Incontinence in Primiparous Women?  International Urogynecology Journal Pelvic Floor Dysfunction 20 (1):61-67.

Boyes SH, Li H, Mori T, Osterweil P, Guise JM (2009).  Effect of Mode of Delivery on the Incidence of Urinary Incontinence in Primiparous Women.  Obstetrics & Gynecology 113(1):134-141.

Sidranksy E, Pastores GM, Mori M (2009).  Commentary.  Dosing Enzyme Replacement Therapy for Gaucher Disease:  Older, But Are We Wiser?  Genetics in Medicine 11(2):90-91.